Get startedLog in
    Picture of Santhera Pharmaceuticals Holding AG logo

    SANN — Santhera Pharmaceuticals Holding AG News Story

    0.000.00%
    ch flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapMomentum Trap
    All News

    Brief: Santhera Pharmaceuticals Completes Enrollment Of Phase 3 Sideros Study With Puldysa

    Picture of Santhera Pharmaceuticals Holding AG logoSanthera Pharmaceuticals Holding AG
    20/05/2020 06:05
    May 20 (Reuters) - Santhera Pharmaceuticals Holding AG
 SANN.S :
    * COMPLETES ENROLLMENT OF PHASE 3 SIDEROS STUDY WITH
PULDYSA®
(IDEBENONE) IN DUCHENNE MUSCULAR DYSTROPHY (DMD)

Source text for Eikon:  ID:nGNE4S302n 
Further company coverage:  SANN.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

    Recent news on Santhera Pharmaceuticals Holding AG

    See all news